For instance, mice infected with a genetically engineered C. neoformans H99 reference strain expressing the type-1 cytokine IFNγ are able to clear the infection, suggesting that IFNγ supplementation may have therapeutic benefits for treating cryptococcal meningitis [115]. This evidence concerns the gene IFNG and Cryptococcal meningitis.